Published, peer-reviewed research shows a patent-pending, virus-mimicking platform technology developed at Purdue University ...
Johnson & Johnson gained Inlexzo, formerly known as TAR-200, when it acquired privately held Taris Biomedical in 2019. The deal gave J&J a treatment it says could change way the “non-muscle invasive” ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback